Medicare Enrolled
Dr. Shinko Lin, M.D.
Dermatology · La Mesa, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lin
Dr. Shinko Lin is a dermatology specialist in La Mesa, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Lin performed 5,684 Medicare services across 2,737 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lin received a total of $4,335 from 30 pharmaceutical and/or device companies across 193 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 21% volume in CA
$4,335 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,684
Medicare services
Top 21% in CA for dermatology
2,737
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~379 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,147 | $6 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
759 | $65 | $148 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
577 | $39 | $114 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
466 | $63 | $121 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
367 | $82 | $197 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
187 | $91 | $209 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
160 | $43 | $94 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
145 | $84 | $210 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
135 | $61 | $175 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
94 | $143 | $288 |
| Skin growth shaving, 0.5 cm or less This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs. |
91 | $59 | $176 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
75 | $134 | $303 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
62 | $72 | $183 |
| Pathology tissue examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis. |
50 | $38 | $74 |
| Shaving of small skin growth on face or mouth area A minor procedure to shave off a small skin growth, measuring 0.5 cm or less, located on the face, ears, eyelids, nose, lips, or mouth. |
46 | $78 | $200 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
43 | $236 | $517 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
41 | $1 | $2 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
36 | $29 | $96 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth measuring 0.6 to 1.0 cm from the scalp, neck, hands, feet, or genitals. |
34 | $106 | $211 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
30 | $44 | $86 |
| Shaving of skin growth on face, 0.6-1.0 cm This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters. |
27 | $110 | $234 |
| Skin tag removal, 1-15 tags This procedure involves the removal of one to fifteen skin tags. It is a minor surgical intervention to excise these benign growths from the skin. |
26 | $49 | $154 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
25 | $108 | $413 |
| Shaving of skin growth, 0.5 cm or less Removal of a small skin growth by shaving it off the surface. This procedure is performed on the scalp, neck, hands, feet, or genitals. |
19 | $63 | $182 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $128 | $275 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
13 | $113 | $217 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
13 | $123 | $468 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,335
Total received (2018-2024)
Avg $619/year across 7 years
Top 31% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
193
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,335 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,834
2023
$875
2022
$407
2021
$475
2020
$120
2019
$357
2018
$266
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$358
E.R. Squibb & Sons, L.L.C.
$252
Regeneron Healthcare Solutions, Inc.
$191
GENZYME CORPORATION
$189
Incyte Corporation
$159
Arcutis Biotherapeutics, Inc.
$155
PFIZER INC.
$109
LEO Pharma Inc.
$82
Galderma Laboratories, L.P.
$63
Dermavant Sciences, Inc.
$58
Boehringer Ingelheim Pharmaceuticals, Inc.
$52
REVANCE THERAPEUTICS, INC.
$47
Janssen Biotech, Inc.
$35
Almirall LLC
$35
STRATA Skin Sciences, Inc.
$30
UCB, Inc.
$20
Top 3 companies account for 43.6% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$589
GENZYME CORPORATION
$546
Regeneron Healthcare Solutions, Inc.
$390
ABBVIE INC.
$387
E.R. Squibb & Sons, L.L.C.
$314
Dermavant Sciences, Inc.
$307
Incyte Corporation
$215
Arcutis Biotherapeutics, Inc.
$210
Galderma Laboratories, L.P.
$194
LEO Pharma Inc.
$175
AbbVie Inc.
$175
Boehringer Ingelheim Pharmaceuticals, Inc.
$101
Almirall LLC
$98
DUSA Pharmaceuticals, Inc.
$90
Lilly USA, LLC
$62
SUN PHARMACEUTICAL INDUSTRIES INC.
$60
AbbVie, Inc.
$49
REVANCE THERAPEUTICS, INC.
$47
Sun Pharmaceutical Industries Inc.
$47
DERMIRA, INC.
$46
Janssen Biotech, Inc.
$35
STRATA Skin Sciences, Inc.
$30
Ortho Dermatologics, a division of Bausch Health US, LLC
$28
Celgene Corporation
$25
Mylan Pharmaceuticals Inc.
$24
UCB, Inc.
$20
SANOFI-AVENTIS U.S. LLC
$20
Taro Pharmaceuticals USA, Inc.
$19
Biofrontera Inc.
$15
Mission Pharmacal Company
$15
Top 3 companies account for 35.2% of all-time payments
Associated products mentioned in payments ›
0.25% · 20% · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · Absorica LD · Avar · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · Bimzelx · CIBINQO · Clindamycin Phosphate and Benzoyl Peroxide · DAXXIFY · DUOBRII · DUPIXENT · ENSTILAR · EPIDUO FORTE · EUCRISA · Humira · Klisyri · LEVULAN KERASTICK · LIBTAYO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · OPZELURA · ORACEA · RINVOQ · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · VTAMA · Winlevi · XTRAC · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Dermatologists within 10 mi
236
Per 100K population
7.2
County median income
$102,285
Nearest hospital
GROSSMONT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lin is a clinical cardiology specialist, with above-average Medicare volume (top 21% in CA), with low-engagement industry engagement, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lin experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Lin performed 2,147 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lin receive payments from pharmaceutical companies?
Yes. Dr. Lin received a total of $4,335 from 30 companies across 193 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lin's costs compare to other dermatologists in La Mesa?
Dr. Lin's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in La Mesa
Browse dermatologists in La Mesa ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in CA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in CA
Which CA dermatologists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology